check_circleStudy Completed

Bacterial Infection

Bayer Identifier:

Trial_1131

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

EU CT Number:

Not Available
Ciprofloxacin in the treatment of pediatric patients with cystic fibrosis episodes caused by sensitive gram negative and gram positive bacteria

Trial purpose

Please see attached Study Results Summary below

Key Participants Requirements

Sex

N/A

Age

10 - 17 Years
  • -

  • -

Trial summary

Enrollment Goal
24
Trial Dates
March 1989 - July 1990
Phase
Phase 3
Could I Receive a placebo
N/A
Products
Cipro (Ciprofloxacin hydrochloride, BAYO9867)
Accepts Healthy Volunteer
N/A

Trial design

Efficacy and safety of ciprofloxacin in the treatment of pediatric patients with cystic fibrosis episodes caused by sensitive gram negative and gram positive bacteria
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.Click here to find results for studies related to marketed products.